Neumarker Inc. Information

Neumarker is an AI-native TechBio company pioneering precision brain health through a proprietary multimodal Brain Intelligence platform. The platform is designed to advance precision neuromedicine, accelerate CNS drug discovery and development, and transform neurological care through an adaptive Neuro Copilot. CNS treatment and drug development are challenged by substantial patient heterogeneity, variable clinical endpoints, placebo effects, and limited objective biomarkers. At the same time, clinicians must navigate fragmented information, delayed or uncertain diagnosis, and a lack of objective decision support for treatment selection. Neumarker is addressing these unmet needs by building an AI-native Brain Intelligence platform that serves as an intelligence layer for brain health, integrating multimodal data to support more precise treatment decisions, more efficient drug development, and transform clinical care.